Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
Generation of oligodendroglial cells by direct lineage conversion.
Dark microglia: A new phenotype predominantly associated with pathological states.
The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination.
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Early recognition and diagnosis of multiple sclerosis.
Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
The intention to exercise and the execution of exercise among persons with multiple sclerosis - a qualitative metasynthesis.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
B cell exchange across the blood-brain barrier in multiple sclerosis.
Methods and measures: what's new for MS?
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Tumefactive demyelination: an approach to diagnosis and management.
Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis.
Environment may play significant role in multiple sclerosis.
Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function.
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
Averting inflammation by targeting the cytokine environment.
The effect of intravenous immunoglobulin on neuromyelitis optica.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].

Pages